Lemonade: Q3 Earnings Snapshot

Lemonade (LMND) reported a Q3 loss of $43.7M, or 56 cents per share, beating analyst expectations of a 60 cent loss. Revenue was $336.1M, exceeding forecasts of $322.1M. The company expects Q4 revenue of $342M-$346M and full-year revenue of $1.23B-$1.24B.

Original reporting
Published Nov 5, 2026, 11:15 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 5, 2026, 11:27 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Lemonade: Q3 Earnings Snapshot — source image
Decision brief

The 30-second read

$LMNDBullishMed
01

Why it matters

The earnings surprise could trigger after‑hours buying pressure, though the company remains loss‑making and guidance is modest.

02

Market read

Primary earnings disclosure for a listed insurtech company; fresh data may affect short‑term price action.

03

What to watch

Full‑year revenue guidance of $1.23‑$1.24B suggests limited upside despite the quarterly beat.

Relevance 7/10Novelty 8/10Timing: after‑hours release

Background

Lemonade, Inc. (LMND) released its Q3 2026 earnings, showing a loss but beating analyst expectations on both loss per share and revenue.

Company-level read

Ticker impact

$LMNDBullishHigh confidence
Context

Q3 loss of $43.7M ($0.56 per share) beat the $0.60 consensus loss estimate and revenue of $336.1M topped the $322.1M forecast.

Expected impact

likely upward pressure as the market prices in the earnings beat.

Evidence & confidence

The surprise beat on loss and revenue is fresh data that can move the stock in after‑hours trading.

Market effects

Insurance‑tech sector may see a modest uplift from LMND's beat.

U.S. equity markets, especially the fintech niche.

Limited to investors tracking U.S. insurtech stocks.

Counterpoint

The beat may be short‑lived; the company still posted a loss and guidance remains modest.

Key entities

  • Lemonade, Inc.

    U.S. listed insurtech firm (ticker LMND).

Related articles

$LMNDMed

Lemonade stock price target lowered to $45 by Keefe Bruyette

Keefe Bruyette & Woods lowered its price target on Lemonade Inc. (NYSE:LMND) to $45 from $48, citing higher growth spending and operating expenses. The firm noted Lemonade's premium growth exceeds 30% and revenue grew nearly 70% in the last twelve months. Lemonade reported Q3 2026 earnings, exceeding expectations with revenue of $336.1 million and adjusted loss of $0.56 per share.

$LMNDMed

Lemonade Q3 Earnings Call Highlights

Lemonade (LMND) reported Q3 operating expenses rose 36% YoY, driven by higher sales and marketing, and administrative costs. Adjusted free cash flow was $27M, with $1.2B in cash. Lemonade Car's premium grew 63% YoY, and the company expects slower growth spending. Loss ratios varied by product, with pet insurance under pressure. The company plans to discuss AI initiatives at its investor day.

$LMNDHighAI 8/10

Lemonade (LMND) Q3 2026 Earnings Call Transcript

Lemonade (LMND) reported Q3 2026 results: $1.55B in-force premium (+34%), $336.1M revenue (+73%), $118.1M gross profit (+48%), and $20.4M adjusted EBITDA loss (improved from prior year). Customer base grew 23% to 3.5M, with premium per customer up 9% to $440. Gross loss ratio increased to 65% due to inflation and weather events. Management expects Q4 adjusted EBITDA to be positive and full-year revenue between $1.23B and $1.235B.

$LMNDMed

Lemonade Inc (LMND) (Q3 2026) Earnings Call Highlights: Record Premium Growth and a Clear

Lemonade Inc (LMND) reported Q3 2026 earnings, highlighting record premium growth and strategic advantages from AI agents. CEO Daniel Schreiber noted AI's potential to favor Lemonade over incumbents. CFO Tim Bixby discussed car insurance loss ratios, G&A expenses, and pet insurance trends. The company expects accelerated state rollouts and cross-sales growth, with no significant incremental customer acquisition costs for cross-sold products.